"One of the most amazing things I’ve ever seen," clinician-scientist Samuel Hume wrote alongside a video clip posted on X.

SURGERY to remove the bladder of cancer patients could be avoided in thousands of cases thanks to a new drug combination. People with advanced tumours appear to be more likely to survive and stay

Cancer research breakthroughs, the dangers of tanning and weight loss drug warnings. These are today's health headlines. (WKYC)

Medicine is shifting from treating disease to actively outsmarting it, with five major breakthroughs emerging in recent weeks. Retatrutide, a triple-hormone agonist, is showing powerful weight loss and anti-inflammatory effects.

A new once-daily targeted therapy, daraxonrasib, has nearly doubled survival in patients with advanced pancreatic cancer in a landmark Phase 3 trial. Experts are calling it one of the most significant breakthroughs against one of the world's deadliest cancers in decades.

A new injectable therapy is showing positive results in reducing melanoma throughout a five-year period. The personalized mRNA cancer therapy, combined with the cancer immunotherapy drug KEYTRUDA, is a collaboration between Merck and Moderna.

A Wynnewood biotech company founded by one of the region’s most accomplished cancer researchers is betting that artificial intelligence could transform how cancer is detected and treated, writes John George for The Philadelphia Business Journal.

A new drug for six common cancers shrank previously untreatable tumours in a trial involving patients with advanced cancer. The daily pill works by unmasking tumours hiding from the immune system.